Universitätsklinikum Hamburg-Eppendorf (UKE)

Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without previous Systemic Therapy for Improvement of Skin Symptoms: PASI and IGA mod. 2011-Results of the PRIME Study (2017) Reich K, Mrowietz U, Augustin M, Thaci D, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with respect to the Improvement of quality of life: DLQI and SF-36 Results of the PRIME Study (2017) Augustin M, Thaci D, Reich K, Mrowietz U, Kneidl J, Hentschke C, Simang M, et al. Conference contribution SOP-palliative sedation (2017) Oechsle K, Radbruch L, Wolf C, Ostgathe C Journal article Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with regard to compatibility-related Therapeutic Adherence: Safety Results of the PRIME Study (2017) Mrowietz U, Augustin M, Thaci D, Reich K, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis with without previous Systemic Therapy for Improvement of Nail Symptoms: NAPSI Results PRIME Study (2017) Thaci D, Reich K, Mrowietz U, Augustin M, Kneidl J, Hentschke C, Simang M, et al. Conference contribution SOP - Dealing with multidrug-resistant pathogens on the palliative care unit (2017) Ostgathe C, Stachura P, Hofmann S, Van Oorschot B, Oechsle K, Bogdan C, Kunz HB, et al. Journal article Influence of radiotherapy-induced reactive oxygen species on the immunogenic potential of HPV+ in comparison to HPV- HNSCC (2017) Peitz L, Frey B, Rieckmann T, Fietkau R, Gaipl U Conference contribution A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus (2017) Zenner HP, Delb W, Kroener-Herwig B, Jaeger B, Peroz I, Hesse G, Mazurek B, et al. Journal article Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4 (2017) Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, et al. Journal article Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions (2017) Hassel JC, Heinzerling L, Aberle J, Baehr O, Eigentler TK, Grimm MO, Gruenwald V, et al. Journal article